EAM
KALA icon

Eventide Asset Management’s KALA BIO KALA Stock Holding History

Eventide Asset Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,381
Closed -$23.3M – 156
2021
Q1 		$23.3M Hold
1,381
– – 0.34% 86
2020
Q4 		$23.4M Hold
1,381
– – 0.36% 85
2020
Q3 		$25.9M Hold
1,381
– – 0.51% 63
2020
Q2 		$36.3M Buy
1,381
+199
+17% +$5.64M 0.79% 46
2020
Q1 		$26M Buy
+1,182
New +$18.9M 0.84% 47
2017
Q4 		– Sell
-24
Closed -$1.37M – 144
2017
Q3 		$1.37M Buy
+24
New +$1.32M 0.08% 116

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Eventide Asset Management's KALA Position: Q2 2021 in Review

Eventide Asset Management sold out of KALA BIO (KALA) in Q2 2021, closing a stake of 1,381 shares — an estimated $23.3M sold.

Eventide Asset Management first reported a position in KALA in Q3 2017 and held it in 6 quarters. The position peaked at $36.3M in Q2 2020. 97 funds tracked by Wall St. Rank hold KALA as of Q2 2021.

  • Eventide Asset Management reported no remaining KALA BIO position as of Q2 2021 after selling out during the quarter.
  • Eventide Asset Management sold 1,381 KALA BIO shares in Q2 2021, an estimated $23.3M.
  • Eventide Asset Management first reported a position in KALA BIO in Q3 2017 and held it in 6 quarters.
  • Eventide Asset Management's KALA BIO position peaked at $36.3M in Q2 2020.
  • 97 funds tracked by Wall St. Rank held KALA BIO as of Q2 2021.

Based on Eventide Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.